PharmEasy IPO: Why API Holdings withdrew IPO paper, what it said about rights issue? Details here
PharmEasy IPO news: The initial public offer (IPO) of PharmEasy has been withdrawn after the company received capital market regulator SEBI's (Securities Exchange Board of India) go-ahead in February this year.
The initial public offer (IPO) of PharmEasy has been withdrawn after the company received capital market regulator SEBI's (Securities Exchange Board of India) go-ahead in February this year. The IPO was withdrawn due to market conditions and strategic considerations, as per the the company. Now, it plans to raise funds via rights issue.
API Holdings, the parent entity of PharmEasy, on August 20 announced the withdrawal of the draft red herring prospectus (DRHP). The pre-IPO draft papers were filed on November 9 last year. .
"The company is committed to its expansion plans, and is considering to raise funds via a rights issue. Shareholders of the company will receive the letter of offer inviting them to participate in the rights issue. The rights issue will be open for a period of 30 days, starting from on or around the first week of September," the company said.
World Bank estimates Indian economy to grow at 6.3% in FY24; predicts service sector activity to grow at 7.4%
AMFI rejig: IRFC, Polycab and Jio Financial Services among others may enter large-cap category, says Nuvama
IND vs NED Free Live Streaming: When and How to Watch India vs Netherlands ODI World Cup 2023 warm-up Match Live on Web, TV, mobile apps online
Senior Citizen Savings Scheme (SCSS): Know how much return you will get on investment from Rs 1 to Rs 15 lakh in SCSS
ONGC, Oil India under pressure after Centre's windfall tax move; MGL, Gujarat Gas rise post-gas price hike
Earlier, in its DRHP, PharmEasy had stated that it was planning to raise Rs 6,250 crore from the issue. The proceeds were to be used for settling an outstanding debt of Rs 1,929 crore, fund organic growth initiatives aggregating to Rs 1,259 crore, pursue inorganic growth through acquisitions and other strategic initiatives totalling Rs 1,500 crore.
The SEBI had approved the initial public offering of PharmEasy, along with Adar Poonawalla-backed Wellness Forever Medicare and metal recycling firm CMR Green Technologies in mid-February. The three companies were issued observation letters by the market regulator on February 16-17, 2022 after they filed preliminary IPO papers with SEBI between September and November last year.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
Maruti, Tata Motors, Eicher Motors: Auto shares trade mixed; what brokerages suggest ahead of festive season
Gold and Silver price today (October 3, 2023): Precious metal futures trade under pressure; Gold below Rs 57,000
Traders' Diary: Buy, sell or hold strategy on Jubilant FoodWorks, RVNL, LTIMindtree, Federal Bank, AU Small Finance Bank, other a dozen other stocks today
From Maruti Suzuki to Tata Motors: Here's how top auto makers fared in terms of sales in September 2023
Air India's San Francisco flight, once diverted to Russia's Magadan, cancelled on due to operational issues
IND vs NEP LIVE Score, Asian Games 2023 Quarterfinals Match Updates: Ruturaj Gaikwad-led India clash with Nepal in debut Asian Games match in Hangzhou